Post-approval studies (Phase 4)Looking for participantsNCT06354179
What this trial is testing
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)
Who this might be right for
Liver TransplantationImmunosuppression
University Hospital, Limoges 162